- Home
- AXR vs ALEC Comparison
AXR vs ALEC Comparison
Compare AXR & ALEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXR
- ALEC
- Stock Information
- Founded
- AXR 1961
- ALEC 2013
- Country
- AXR United States
- ALEC United States
- Employees
- AXR N/A
- ALEC N/A
- Industry
- AXR Homebuilding
- ALEC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AXR Real Estate
- ALEC Health Care
- Exchange
- AXR Nasdaq
- ALEC Nasdaq
- Market Cap
- AXR 203.2M
- ALEC 176.3M
- IPO Year
- AXR N/A
- ALEC 2019
- Fundamental
- Price
- AXR $32.78
- ALEC $1.71
- Analyst Decision
- AXR
- ALEC Buy
- Analyst Count
- AXR 0
- ALEC 6
- Target Price
- AXR N/A
- ALEC $11.75
- AVG Volume (30 Days)
- AXR 34.8K
- ALEC 1.3M
- Earning Date
- AXR 03-07-2025
- ALEC 02-25-2025
- Dividend Yield
- AXR N/A
- ALEC N/A
- EPS Growth
- AXR N/A
- ALEC N/A
- EPS
- AXR 2.30
- ALEC N/A
- Revenue
- AXR $63,223,000.00
- ALEC $61,508,000.00
- Revenue This Year
- AXR N/A
- ALEC N/A
- Revenue Next Year
- AXR N/A
- ALEC $45.42
- P/E Ratio
- AXR $14.26
- ALEC N/A
- Revenue Growth
- AXR 54.34
- ALEC N/A
- 52 Week Low
- AXR $15.88
- ALEC $1.60
- 52 Week High
- AXR $39.67
- ALEC $7.58
- Technical
- Relative Strength Index (RSI)
- AXR 54.89
- ALEC 33.41
- Support Level
- AXR $27.81
- ALEC $1.60
- Resistance Level
- AXR $32.10
- ALEC $1.82
- Average True Range (ATR)
- AXR 1.31
- ALEC 0.14
- MACD
- AXR 0.31
- ALEC 0.05
- Stochastic Oscillator
- AXR 80.29
- ALEC 19.82
About AXR AMREP Corporation
Amrep Corp through its subsidiaries is engaged in the Real estate business. Its activities include land sales and lease activities, which involve obtaining approvals and selling both developed and undeveloped lots to homebuilders, commercial users, and others, as well as investments in commercial and investment properties. The Company accounts for land sales, home sales, and other revenues. Its operating segments include Land development and Homebuilding. The firm generates a majority of its revenue from the Land development segment. Geographically, all the activities are carried out throughout the United States.
About ALEC Alector Inc.
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.